Prof. Dr. med. Silke Gillessen Sommer
Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology
Droz J, Balducci L, Zulian G, Puts M, Payne H, Oudard S, Mottet N, Hughes S, Gillessen Sommer S, Albrand G, Aapro M. Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology. Eur Urol 2017; 72:521-531.
11.01.2017Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology
11.01.2017Eur Urol 2017; 72:521-531
Droz Jean-Pierre, Balducci Lodovico, Zulian Gilbert, Puts Martine, Payne Heather, Oudard Stephane, Mottet Nicolas, Hughes Simon, Gillessen Sommer Silke, Albrand Gilles, Aapro Matti
Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma
Fischer S, Cohn-Cedermark G, Ståhl O, Chau C, Arriola E, Marti K, Hutton P, Laguerre B, Maroto P, Beyer J, Dieckmann K, Lorch A, Tandstad T, Wheater M, Porfiri E, Flechon A, Aparicio J, Klingbiel D, Skrbinc B, Basso U, Shamash J, Gillessen Sommer S. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma. J Clin Oncol 2016; 35:194-200.
28.11.2016Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma
28.11.2016J Clin Oncol 2016; 35:194-200
Fischer Stefanie, Cohn-Cedermark Gabriella, Ståhl Olof, Chau Caroline, Arriola Edurne, Marti Kalena, Hutton Paul, Laguerre Brigitte, Maroto Pablo, Beyer Jörg, Dieckmann Klaus-Peter, Lorch Anja, Tandstad Torgrim, Wheater Matthew, Porfiri Emilio, Flechon Aude, Aparicio Jorge, Klingbiel Dirk, Skrbinc Breda, Basso Umberto, Shamash Jonathan, Gillessen Sommer Silke
appendix 8: Prostate cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Genitourinary-Cancers)
Parker C, Gillessen Sommer S, Horwich A. appendix 8: Prostate cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Genitourinary-Cancers). Ann Oncol 2016; 27:v146-v147.
01.09.2016appendix 8: Prostate cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Genitourinary-Cancers)
01.09.2016Ann Oncol 2016; 27:v146-v147
Parker C, Gillessen Sommer Silke, Horwich A
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial
Saad F, O'Sullivan J, Federhofer J, Wirth M, Tucci M, Petrenciuc O, Nilsson S, Miller K, Lévy J, Gratt J, Heinrich D, Heidenreich A, Gillessen Sommer S, Carles J. Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial. Lancet Oncol 2016; 17:1306-16.
26.07.2016Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial
26.07.2016Lancet Oncol 2016; 17:1306-16
Saad Fred, O'Sullivan Joe M, Federhofer Judith, Wirth Manfred, Tucci Marcello, Petrenciuc Oana, Nilsson Sten, Miller Kurt, Lévy Jérémy, Gratt Jeremy, Heinrich Daniel, Heidenreich Axel, Gillessen Sommer Silke, Carles Joan
Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)
Cathomas R, Gillessen Sommer S, Manetsch G, Bernhard J, Mohaupt M, Roggero E, Rauch D, Vilei S, Hayoz S, Kenner H, von Burg P, Elliott T, Rothermundt C, Winterhalder R, Mark M, Crabb S, Swiss Group for Clinical Cancer Research SAKK. Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11). Prostate 2016; 76:1519-1527.
25.07.2016Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)
25.07.2016Prostate 2016; 76:1519-1527
Cathomas Richard, Gillessen Sommer Silke, Manetsch Gabriela, Bernhard Jürg, Mohaupt Markus G, Roggero Enrico, Rauch Daniel, Vilei Simona Berardi, Hayoz Stefanie, Kenner Heike, von Burg Philippe, Elliott Tony, Rothermundt Christian, Winterhalder Ralph, Mark Michael, Crabb Simon J, Swiss Group for Clinical Cancer Research SAKK
Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform
Gillessen Sommer S, Gilson C, James N, Adler A, Sydes M, Clarke N. Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform. Eur Urol 2016; 70:906-908.
19.07.2016Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform
19.07.2016Eur Urol 2016; 70:906-908
Gillessen Sommer Silke, Gilson Clare, James Nick, Adler Amanda, Sydes Matthew R, Clarke Noel
Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program
Papazoglou D, Stenner F, Kühne R, Baumann S, Richner J, Schmid M, von Burg P, von Rohr L, Nussbaum C, Mingrone W, Barth A, Winterhalder R, Hasler L, Rothermundt C, Gillessen Sommer S, Cathomas R, Berthold D, Wannesson L, Rothschild S. Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program. Clin Genitourin Cancer 2016
23.06.2016Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program
23.06.2016Clin Genitourin Cancer 2016
Papazoglou Dimitrios, Stenner Frank, Kühne Reto, Baumann Sylvia, Richner Jürg, Schmid Mathias, von Burg Philippe, von Rohr Lukas, Nussbaum Catrina Uhlmann, Mingrone Walter, Barth Andreas, Winterhalder Ralph, Hasler Loretta, Rothermundt Christian, Gillessen Sommer Silke, Cathomas Richard, Berthold Dominik, Wannesson Luciano, Rothschild Sacha I
Reproducible Tissue Homogenization and Protein Extraction for Quantitative Proteomics Using MicroPestle-Assisted Pressure-Cycling Technology
Shao S, Guo T, Gross V, Lazarev A, Koh C, Gillessen Sommer S, Jörger M, Jochum W, Aebersold R. Reproducible Tissue Homogenization and Protein Extraction for Quantitative Proteomics Using MicroPestle-Assisted Pressure-Cycling Technology. J Proteome Res 2016; 15:1821-9.
10.05.2016Reproducible Tissue Homogenization and Protein Extraction for Quantitative Proteomics Using MicroPestle-Assisted Pressure-Cycling Technology
10.05.2016J Proteome Res 2016; 15:1821-9
Shao Shiying, Guo Tiannan, Gross Vera, Lazarev Alexander, Koh Ching Chiek, Gillessen Sommer Silke, Jörger Markus, Jochum Wolfram, Aebersold Ruedi
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Tombal B, Padhani A, Olmos D, Oh W, Nilsson S, Mastris K, Logothetis C, Lecouvet F, James N, Hussain M, Parker C, Rubin M, Tannock I, Sweeney C, Suzuki H, Sternberg C, Small E, Shore N, Sella A, Scher H, Schalken J, Heidenreich A, Gleave M, Smith M, Sartor O, Nelson P, Halabi S, Fizazi K, Efstathiou E, de Bono J, Attard G, Omlin A, Soule H, Akaza H, Fanti S, Eeles R, Drake C, De Santis M, Davis I, Daugaard G, Chinnaiyan A, Beltran H, Beer T, Gillessen Sommer S. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Ann Oncol 2016
02.05.2016Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
02.05.2016Ann Oncol 2016
Tombal B, Padhani A R, Olmos D, Oh W K, Nilsson S, Mastris K, Logothetis C J, Lecouvet F E, James N D, Hussain M, Parker C, Rubin M A, Tannock I F, Sweeney C J, Suzuki H, Sternberg C N, Small E J, Shore N D, Sella A, Scher H I, Schalken J A, Heidenreich A, Gleave M E, Smith M R, Sartor O, Nelson P S, Halabi S, Fizazi K, Efstathiou E, de Bono J S, Attard G, Omlin Aurelius, Soule H R, Akaza H, Fanti S, Eeles R A, Drake C G, De Santis M, Davis I D, Daugaard G, Chinnaiyan A M, Beltran H, Beer T M, Gillessen Sommer Silke
Anti-tumour activity of platinum compounds in advanced prostate cancer—a systematic literature review
Gillessen Sommer S, Omlin A, Hager S. Anti-tumour activity of platinum compounds in advanced prostate cancer—a systematic literature review. Annals of Oncology 2016; 27:975-984.
06.04.2016Anti-tumour activity of platinum compounds in advanced prostate cancer—a systematic literature review
06.04.2016Annals of Oncology 2016; 27:975-984
Gillessen Sommer Silke, Omlin Aurelius, Hager Sonja
Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al
Parker C, Gillessen Sommer S, Heidenreich A, Horwich A. Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al. Ann Oncol 2016; 27:750-1.
22.01.2016Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al
22.01.2016Ann Oncol 2016; 27:750-1
Parker C, Gillessen Sommer Silke, Heidenreich A, Horwich A
Medikamentöse Behandlung des metastasierten Prostatakarzinoms
Cathomas R, Wyler S, Wild P, Thalmann G, Stenner F, Schäfer N, Rentsch C, Müntener M, Jichlinski P, Iselin C, Gillessen Sommer S, Eberli D, Berthold D, Amram M, Aebersold D, Schmid H, Omlin A. Medikamentöse Behandlung des metastasierten Prostatakarzinoms. Schweiz Med Forum 2016; 16:266-72.
01.01.2016Medikamentöse Behandlung des metastasierten Prostatakarzinoms
01.01.2016Schweiz Med Forum 2016; 16:266-72
Cathomas R, Wyler S, Wild P, Thalmann G, Stenner F, Schäfer N, Rentsch C, Müntener M, Jichlinski P, Iselin C, Gillessen Sommer Silke, Eberli D, Berthold D, Amram M-L, Aebersold DM, Schmid Hans-Peter, Omlin Aurelius
Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer
Rothermundt C, Hader C, Gillessen Sommer S. Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer. Ann Oncol 2015
29.11.2015Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer
29.11.2015Ann Oncol 2015
Rothermundt Christian, Hader C, Gillessen Sommer Silke
Minimal sample requirement for highly multiplexed protein quantification in cell lines and tissues by PCT-SWATH mass spectrometry
Shao S, Guo T, Koh C, Gillessen Sommer S, Jörger M, Jochum W, Aebersold R. Minimal sample requirement for highly multiplexed protein quantification in cell lines and tissues by PCT-SWATH mass spectrometry. Proteomics 2015; 15:3711-21.
10.09.2015Minimal sample requirement for highly multiplexed protein quantification in cell lines and tissues by PCT-SWATH mass spectrometry
10.09.2015Proteomics 2015; 15:3711-21
Shao Shiying, Guo Tiannan, Koh Chiek Ching, Gillessen Sommer Silke, Jörger Markus, Jochum Wolfram, Aebersold Ruedi
Reply to the letter to the editor 'Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al
Gillessen Sommer S, Fanti S, Omlin A, panelists and authors of APCCC. Reply to the letter to the editor 'Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al. Ann Oncol 2015; 26:2354-5.
07.09.2015Reply to the letter to the editor 'Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al
07.09.2015Ann Oncol 2015; 26:2354-5
Gillessen Sommer Silke, Fanti S, Omlin Aurelius, panelists and authors of APCCC
Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes
Rothermundt C, Sternberg C, Schmidinger M, Rini B, Porta C, Oldenburg J, McDermott D, Larkin J, Grünwald V, Gillessen Sommer S, Escudier B, Eisen T, Cerbone L, Bailey A, Putora P. Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes. Oncologist 2015; 20:1028-35.
03.08.2015Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes
03.08.2015Oncologist 2015; 20:1028-35
Rothermundt Christian, Sternberg Cora, Schmidinger Manuela, Rini Brian, Porta Camillo, Oldenburg Jan, McDermott David, Larkin James, Grünwald Viktor, Gillessen Sommer Silke, Escudier Bernard, Eisen Tim, Cerbone Linda, Bailey Alexandra, Putora Paul Martin
Assessment of Anticancer-Treatment Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer - Going beyond PSA and Imaging, a Systematic Literature Review
Schmid S, Omlin A, Blum D, Strasser F, Gillessen Sommer S, Rothermundt C. Assessment of Anticancer-Treatment Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer - Going beyond PSA and Imaging, a Systematic Literature Review. Ann Oncol 2015
27.07.2015Assessment of Anticancer-Treatment Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer - Going beyond PSA and Imaging, a Systematic Literature Review
27.07.2015Ann Oncol 2015
Schmid Sabine, Omlin Aurelius, Blum D, Strasser Florian, Gillessen Sommer Silke, Rothermundt Christian
Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Parker C, Gillessen Sommer S, Heidenreich A, Horwich A, ESMO Guidelines Committee. Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26 Suppl 5:v69-77.
22.07.2015Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
22.07.2015Ann Oncol 2015; 26 Suppl 5:v69-77
Parker C, Gillessen Sommer Silke, Heidenreich A, Horwich A, ESMO Guidelines Committee
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Tombal B, Padhani A, Olmos D, Oh W, Nilsson S, Mastris K, Logothetis C, Lecouvet F, James N, Hussain M, Parker C, Rubin M, Tannock I, Sweeney C, Suzuki H, Sternberg C, Small E, Shore N, Sella A, Scher H, Schalken J, Heidenreich A, Gleave M, Smith M, Sartor O, Nelson P, Halabi S, Fizazi K, Efstathiou E, de Bono J, Attard G, Omlin A, Soule H, Akaza H, Fanti S, Eeles R, Drake C, De Santis M, Davis I, Daugaard G, Chinnaiyan A, Beltran H, Beer T, Gillessen Sommer S. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Ann Oncol 2015; 26:1589-604.
03.06.2015Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
03.06.2015Ann Oncol 2015; 26:1589-604
Tombal B, Padhani A R, Olmos D, Oh W K, Nilsson S, Mastris K, Logothetis C J, Lecouvet F E, James N D, Hussain M, Parker C, Rubin M A, Tannock I F, Sweeney C J, Suzuki H, Sternberg C N, Small E J, Shore N D, Sella A, Scher H I, Schalken J A, Heidenreich A, Gleave M E, Smith M R, Sartor O, Nelson P S, Halabi S, Fizazi K, Efstathiou E, de Bono J S, Attard G, Omlin Aurelius, Soule H R, Akaza H, Fanti S, Eeles R A, Drake C G, De Santis M, Davis I D, Daugaard G, Chinnaiyan A M, Beltran H, Beer T M, Gillessen Sommer Silke
On Nonharming: The Debate Continues in Stage I Testicular Cancer
Gillessen Sommer S, De Santis M, Rothermundt C. On Nonharming: The Debate Continues in Stage I Testicular Cancer. J Clin Oncol 2015
01.06.2015On Nonharming: The Debate Continues in Stage I Testicular Cancer
01.06.2015J Clin Oncol 2015
Gillessen Sommer Silke, De Santis Maria, Rothermundt Christian